came from a fraction at the interface between 25% and 60% sucrose, where aggregates composed of amorphous material and flattened rods measuring 25 nm ϫ 100-200 nm were observed. The enriched activity was inactivated by proteinase K, diethylpyrocarbonate, urea, chaotropes, phenol, and SDS, but was not abolished by nuclease treatments or UV irradiation. This behavior, typical of a protein, gave rise to the name attached by Prusiner and coworkers, "prion," for proteinaceous infectious particle ; see also Prusiner et al., 1980) .
The same workers identified a protein, designated PrP, resistant to limited proteinase K digestion, that was specifically present in infected hamster brain but not in normal brain and exhibited a relative migration in SDS-PAGE of 27-30 kDa Prusiner et al., 1982) . Whether this species was a byproduct of infection, or was directly responsible, could not be immediately distinguished, although the copurification of , 1996; and Lasmézas et al., 1996b) . The third panel is a section ubilized infected brain extract was carried out, showing immunostained after hydrolytic autoclaving (Muramoto et al., 1992) with anti-PrP antiserum, revealing the presence of PrP in the plaque several 1000-fold enrichment of both PrP 27-30 and lesions of GSS.
infectivity (Gabizon et al., 1988) . This was consistent (Middle Row) Spongiform changes typical of CJD. Section obtained with the notion that there is tight linkage between from an affected transgenic mouse, carrying a chimeric mouseinfectivity and the presence of some form of the PrP human-mouse transgene, that had been inoculated with brain hoprotein. Nonetheless, despite years of effort, even in the mogenate from a human sporadic CJD case (from DeArmond and purest samples, the ratio of PrP molecules to infectious Prusiner, 1995, with permission) . (Bottom Row) Histoblot analysis to contain less than one molecule of nucleic acid larger than ‫001ف‬ nt for a particle-to-infectivity ratio near unity ranging from a replicating polysaccharide to a nucleo- (Kellings et al., 1992) . Thus, it seems likely that demonprotein complex (for review, see . Among stration of the protein only hypothesis will require the these models was a prescient speculation, in which Grifproduction of infectious particles in vitro from purified fith suggested that "conversion" of a protein from a PrP protein (that has a level of impurity of less than 1 normal energetically favored conformation to another part per infectious unit). conformation, either spontaneously or by exogenous introduction of the altered conformation, could explain Prion Protein Is Host Encodedthese diseases (Griffith, 1967) .
A Conversion Process The molecular nature of the infectious agent lay largely Purification of PrP 27-30 made it possible to obtain NH2-untested for 15 years until Stanley Prusiner and coworkterminal amino acid sequence (Prusiner et al., 1984) and, ers achieved the biochemical enrichment of infectious ultimately, cDNA clones encoding PrP protein (Oesch activity and showed its association with a specific proet al., 1985; Chesebro et al., 1985) . PrP mRNA proved tein. In early 1982, Prusiner and coworkers reported a to be the product of a single host cell nuclear gene. 1000-fold enrichment of scrapie infectivity from homogThe primary structure of PrP encoded by the gene of a enate of infected brain, achieved through a series of normal animal was found to be identical to that encoded steps including polyethylene glycol precipitation, microby a cDNA from a scrapie-infected animal (Basler et al., coccal nuclease digestion, limited proteinase K diges-1986) , and similar levels of mRNA were found in both tion, and sucrose density gradient centrifugation (Prusisettings (Chesebro et al., 1985; Oesch et al., 1985) . Antibodies generated against PrP 27-30 identified the PrP ner et al., 1982; . The highest activity protein not only in the brain of uninfected animals but 1996, and Figure 3 ). For example, many GSS kindreds, including the original GSS family, harbor an amino acid also in many visceral tissues as a 33-35 kDa glycosylated species, termed PrP C . A protein of identical size substitution, P102L (Hsiao et al., 1989) . In the case of sporadic CJD, most patients are homozygous for a polywas also observed in scrapie-infected brain extracts. Strikingly, when limited proteinase K digestion was carmorphism at residue 129 (encoding either methionine or valine), in the absence of any other mutation (Palmer ried out, PrP C was completely degraded, whereas a fraction of the protein in infected brain, termed PrP Sc , was et al., 1991) . Similarly, the recent early-onset CJD cases potentially related to BSE exposure have affected indionly partially cleaved, removing 66 NH 2 -terminal amino acids to produce the species PrP 27-30. Thus, the PrP viduals homozygous for M129 . Interestingly, the corresponding mouse residue lies in the small, protein appears to have at least two distinct conformational states: a protease-sensitive one found ubiquitwo-stranded ␤ sheet region of the recently determined mouse PrP121-231 structure; this ␤ sheet has been tously, and a protease-resistant one in the setting of infection. Perhaps linked to such protease-resistant besuggested to provide a nucleation point for conformational change during conversion (Riek et al., 1996 ; see havior is the additional observation that, while PrP C is a soluble protein, the PrP Sc form is stubbornly insoluble, Figure 3B ). Two different genetic studies with mice have provided localizing in the amorphous aggregates in enriched fractions from infected brain (e.g., Meyer et al., 1986) . In any perhaps the strongest evidence arguing that infectious particles are generated from the endogenous PrP C procase, the protease resistance of the PrP Sc form has been relied on to allow the detection of PrP Sc in situ in both tein. In one, spontaneous prion disease was observed in uninoculated transgenic mice expressing a mouse experimental and clinical diagnosis. This is accomplished by pretreatment with proteinase K to remove PrP with a substitution homologous to that in GSS patients (Hsiao et al., 1990; Hsiao et al., 1994 ; Telling et PrP C , followed by guanidine treatment to expose epitopes of PrP Sc for immunolocalization (Taraboulos et al., al., 1996a) . Importantly, brain homogenates from these mice can transfer prion disease when inoculated into 1992, and see Figure 1 histoblot).
Given the same primary structure of PrP C and PrP Sc , transgenic mice expressing low levels of the same mutant PrP protein, that would not otherwise develop disthe process whereby the normal state of PrP protein is "converted" to the infection-associated form seemed ease (Hsiao et al., 1994; Telling et al., 1996a) . Thus, all the components required to form infectious particles likely to involve either posttranslational modification or a change in conformation (e.g., Hope et al., 1986) . Extenappear to be present endogenously in the mice. Moreover, it appears that removal of the endogenous PrP sive biochemical characterization has failed to find any covalent difference between the PrP C and PrP Sc proteins gene in the latter study led to earlier onset of disease and more severe pathology in the uninoculated transgenic (e.g., Stahl et al., 1993) . By contrast, physical measurements have demonstrated a dramatic conformational strain, reflecting that the presence of wild-type PrP somehow interfered with disease production from the difference in the PrP forms. For example, Fourier transform infrared spectosocopy and circular dichroism indimutant transgene.
In a second avenue of study, a requirement for PrP C cate that the ␣-helical content of the PrP C form is ‫,%04ف‬ with little or no ␤ sheet (Pan et al., 1993) . By contrast, protein in generating infectivity was demonstrated directly-mice with a disruption in the endogenous PrP the PrP 27-30 form contains 50% ␤ sheet and only ‫%02ف‬ ␣ helix (Caughey et al., 1991; Pan et al., 1993;  gene (Prnp 0/0 ) were both resistant to prion disease and unable to generate new infectious particles (Bü eler et al., Safar et al., 1993) . The recently presented solution structure of a fragment of the mouse PrP C has allowed a 1993; Prusiner et al., 1993) . A straightforward hypothesis suggested by these observations is that endogenous direct determination of secondary structure content of this portion of PrP C (Riek et al., 1996) . The agreement PrP C is converted to PrP Sc conformation by the action of an infectious form of the PrP molecule. However, with the FTIR study is excellent: out of 109 resolvable residues in the PrP 121-232 species, 43 lie in ␣ helix given the low specific activity of even the purest PrP Sc samples and the observation that under some circum-(40%), while only 8 residues lie in two short antiparallel ␤ strands (7%) (see Figure 3B) . stances it appears that there can be both disease and infectivity in the absence of protease-resistant material (e.g., the GSS mice), it remains possible that the infecThe Conversion Process-Endogenous PrP C tious form of PrP is distinct from the protease-resistant as the Target for "Infectious" PrP Sc
PrP
Sc form. The notion that endogenous PrP C was involved with the development of infection was first supported by the observation that two strains of mice that had genetically Conversion Produces Host-Specific Prions and Is Restricted by Interspecies ''Barriers'' determined long versus short incubation times in the face of prion exposure contained specific codon differ-
The nature of the putative interaction between PrP C and PrP Sc that mediates conversion has been probed in vivo ences present at two positions in the PrP C gene (Westaway et al., 1987) . Subsequently, PrP genes in families in transgenic mouse experiments. Studies of the "species barrier" have been particularly revealing. The spewith GSS, FFI, and CJD were found to encode either specific amino acid substitutions or particular polymorcies barrier is the phenomenon in which one species tends to be resistant to infection by prion particles genphisms (including insertion/deletion of members of an "octa repeat" motif in the NH 2 -terminal portion) that erated in another. For example, higher primates were thought to be resistant to infection from ungulates, e.g., could be linked to development of disease (see Prusiner, cows, until the recent cases of a new variant of CJD, termed vCJD, and the transmission of BSE to macaques. Moreover, mice are normally resistant to infection from the widely used 263K strain of hamster prion but become susceptible to this strain of hamster PrP Sc (Scott et al., 1989) following transgenic introduction of the hamster PrP gene. Correspondingly, disruption of the endogenous mouse gene and introduction of a hamster transgene renders mice highly susceptible to hamster prions and resistant to mouse prions (Bü eler et al., 1993; Prusiner et al., 1993) . This data is most easily reconciled with a model in which there is a direct interaction between the infecting PrP Sc and endogenous PrP C , and in which that effective interaction is inhibited by differ- sequence . Correspondingly, if the one, might also be involved in the conversion process (see text).
transgenic animals were inoculated with mouse prions, mouse PrP Sc was observed in the infected brain. hamster, mouse, and the hamster-mouse chimeras was The location in the PrP C structure of the homologous reproduced by the in vitro reaction . interaction with PrP Sc was probed by producing Moreover, there was preservation of "strain" specificity transgenic mice bearing chimeric genes. When the in vitro (discussed below), insofar as the distinct proteinmidportion of the hamster sequence (codons 94-188), ase K resistance patterns of PrP Sc from two mink prion differing at 5 residues from mouse, was substituted for strains, presumably reflecting different PrP Sc conformathe corresponding region of mouse PrP, the transgenic tions, were reproducible in the in vitro system (Bessen mice were observed to become susceptible to hamster et al., 1995). prions, producing, as expected, chimeric PrP Sc and see Figure 3A) .
Models for the Conversion of PrP C to PrP Sc
While the notion that a misfolded form of a protein could catalyze the refolding of native molecules into a distinct Conversion In Vitro Despite considerable effort, it has not been possible to "misfolded" conformation might seem radical, such a process is by no means physically unreasonable. Two demonstrate the production of infectious particles in vitro. However, Caughey, Lansbury, and coworkers have distinct mechanisms have been proposed to account for such behavior Prusiner, 1991 ; Jardemonstrated the ability of PrP Sc to convert PrP C in vitro to a form that has proteolytic resistance resembling that rett and Lansbury, 1993; Cohen et al., 1994 ; Figure 2 ). In one model, formation of PrP Sc is a nucleation-dependent of PrP Sc . In these studies, when metabolically-labeled PrP C isolated by immunoprecipipolymerization process. In the absence of a preexistent aggregate, the conversion between PrP C and PrP Sc is tation was treated with 3 M guanidine HCl and then diluted into a 50-fold excess of purified nonlabeled reversible, but PrP Sc monomer is less stable than PrP C . PrP Sc aggregates, however, promote the conversion of PrP Sc , a portion was converted to a relatively proteaseresistant form, which generated a species resembling PrP C by binding to and stabilizing the otherwise unfavored PrP Sc conformation. The barrier to a stable converPrP 27-30 upon proteinase K digestion. Because only a small amount of material was converted to a proteasesion process thus lies at the level of the initial nucleation process, in which formation of low order aggregates is resistant form and because this occurred in the presence of an excess of PrP Sc , biological assay of the nanot favored, since the free energy gained from intermolecular interactions does not outweigh the entropic cost scent protease-resistant material by measurement, for example, of infectivity was not possible. Interestingly, of binding until a minimum size nucleus is attained. The requirement that a nucleus be formed before conversion pretreatment of PrP Sc with 3 M guanidine HCl, which produced reversible unfolding of PrP Sc , increased the is stable predicts certain characteristics of the aggregation process, including dependence on exceeding a critextent of conversion, suggesting that PrP Sc itself may also need to undergo a conformational change for conical protein concentration for the initial formation of aggregates, and kinetics displaying a lag phase. The in version to proceed, potentially accounting for the high particle:infectivity ratio. Supporting the proposal that vitro conversion process appears to show such features , but whether a PrP Sc nucleus is the in vitro reaction faithfully reproduced that in vivo, species specificity in the conversion reaction between already present is unclear from the design of the study.
The relatively large size of the minimum stable nucleus kinetically inaccessible. Infectious prion disease could would tend to make such a particle insoluble and could then result if PrP Sc were able to accelerate the convertherefore account for the observation in the in vitro reacsion of PrP C to PrP Sc in a manner analogous to the catation that fractions containing higher-order PrP Sc aggrelyzed conversion between the I and N states of ␣-lytic gates greater than 300 kDa in size could mediate the protease. conversion to protease resistance while smaller-sized
It is important to note that the nucleation and catafractions could not. Infection would thus circumvent the lyzed conversion mechanisms are not mutually excluslow step of nucleation by introducing a "seed" that sive. For example, there could be a hybrid mechanism initiates aggregation.
by which the surface of an aggregate, which is initially In a second proposed mechanism, the PrP Sc form is formed by a nucleation process, catalyzes the conforinherently more stable than PrP C , but kinetically inaccesmational change of unconverted monomers. Indeed, in sible (Prusiner, 1991; Figure 2) . In this case, PrP
Sc could the case of flagella formation in vitro, kinetic studies promote conversion by catalyzing the rearrangement of show a lag between the initial, reversible, binding, and a molecule of PrP C , or of a partially destabilized intermestable incorporation into the flagellum (Asakura, 1968 Other amyloid-forming diseases offer further opportuFor both of the proposed mechanisms, there are physnity for examining the mechanism of conformational reical precedents. In the case of nucleation-polymerizaarrangement. There are at least 15 human diseases in tion, there is a resemblance to tubulin polymerization, which an accumulation of a specific protein can occur crystal growth, sickle hemoglobin formation, viral capsid in characteristic insoluble fibers known as amyloid, assembly, and bacterial flagellar polymerization. Flagelwhich are typically 60-100 Å in diameter and exhibit lar polymerization may be particularly instructive. The characteristic birefringence when stained with the dye soluble monomer unit, flagellin, becomes incorporated Congo Red (for review, see Kelly, 1996) . These amyloid into the growing end of a flagellum (Asakura et al., 1964, diseases result in a variety of different clinical presenta-1966). Monomers in solution, even at nearly millimolar tions, dependent on the sites of amyloid deposition, and concentration, occupy a conformation unable to spontainclude Alzheimer's disease, where neurodegeneration neously nucleate, but if a seed of fragmented flagellum occurs in association with deposition of the amyloid ␤ is placed into the mixture, then polymerization rapidly protein. Despite distinct folds in the native state, all of ensues. Interestingly, the polymerizing monomers can the proteins involved in these diseases undergo conforassume the conformation of even heterologous seed mational alteration to a common structure in the amyloid material, reflecting a "templating" behavior. It should be fibril, a "cross ␤" repeat structure in which ␤ strands pointed out that while the foregoing "aggregates" adopt are aligned perpendicular to the axis of the amyloid a regular repeating structure, there is nothing in the fiber. A recent fiber diffraction study with synchrotron physics underlying a nucleation process that requires radiation suggests that, in fact, it is ␤ sheets that are that the aggregates formed must have long-range order.
positioned perpendicular to the fiber axis and that they There is also precedent for the template-assisted, catare arrayed as a continuous helix (Blake and Serpell, alyzed conversion mechanism, in which PrP C is a meta-1996). As with prion disease, the other amyloidoses can stable conformation that does not spontaneously form be initiated by inherited mutations in the respective codthe more stable PrP Sc at any appreciable rate. During ing sequences, which apparently destabilize the native the past few years, a number of proteins have been state of these proteins, enabling them to rearrange to the observed to occupy such conformations under kinetic common conformation in amyloid. Such destabilization control, i.e., they are separated from their true free enhas been elegantly demonstrated recently for two puriergy minima by a large barrier. These include influenza fied amyloidogenic lysozyme variants-while they were hemagglutinin (Baker and Agard, 1994a) , the serpin famenzymatically active and crystallized in conformations ily of protease inhibitors (Sifers, 1995) , and a number nearly identical to wild-type, they exhibited little or no of proteases including subtilisin and ␣-lytic protease protection from deuterium exchange when incubated in (Baker and Agard, 1994b) . This last case of ␣-lytic protesolution at 37ЊC, unlike wild type (Booth et al., 1997) . ase is particularly revealing. Here, the interconversion Lysozyme fibrils isolated from patient material, however, between a molten globule-like intermediate, I, and the contained only the mutant lysozymes-the wild-type native state, N, is extremely slow, allowing little or no protein present in the heterozygous individuals was not conversion over the course of a month (reflecting a barrecruited. This underscores the major difference that rier of ‫52ف‬ kcal/mole). Conversion, however, is dramatisets prion disease apart from other amyloidoses, namely cally accelerated by binding of the naturally-occurring that the aggregated form of PrP is also able to promote propeptide region, in either cis or trans, allowing folding the rearrangement of unmutated protein, thereby allowto N to occur within minutes (the propeptide lowers ing transmission of disease. the barrier by ‫41ف‬ kcal/mole). This behavior raises the Recent studies with another amyloidosis, familial ampossibility that folding of PrP is also under kinetic control, with the PrP Sc state thermodynamically favored but yloidotic polyneuropathy, provide further insight into an amyloidogenic conversion process (Kelly, 1996 ; Lai et distribution of CNS involvement, and even pattern of proteolytic cleavage of PrP Sc . These properties are real., 1996). The involved protein, transthyretin (TTR), is, in native form, a homotetramer whose subunits are eighttained even after repeated passage, as revealed by experiments in isogenic mice (e.g., Fraser and Dickinson, stranded ␤ sheet sandwiches. In vitro, upon exposure to pH 4-5, TTR dissociates to monomers that undergo 1973; Bruce et al., 1976; Kimberlin et al., 1989; Carp and Callahan, 1991; . Strikingly, there tertiary structural rearrangement, and amyloid formation ensues (Lai et al., 1996) . As with prion conversion, conappear to be conformational differences in PrP Sc that correlate with such behavior. A particularly good examtrol of TTR amyloid formation could lie either at the step of production of the amyloid aggregate or at the step of ple of this is the observation in transmissible mink encephalopathy of two distinct presentations of faithfully monomer rearrangement, invoking kinetic control. Both mechanisms have been observed with TTR in vitro. In transmissible disease, hyper (HY) and drowsy (DY), that describe the behavior of the affected animals, which support of a nucleation step, fibril formation was observed to exhibit a lag phase and to be accelerated are associated with characteristic incubation times and locations of neuropathology. The two presentations after initiation by addition of amyloidogenic monomer. In support of kinetic control, a greater amount of TTR were found to be associated also with characteristic degrees of proteinase K susceptibility of PrP Sc , with paramyloid was formed at pH 4.4 during refolding from denaturant than was observed starting with native protial treatment producing different NH 2 termini Marsh, 1992, 1994 specific properties, although this modification does not appear to be necessary for acquisition of a proteinase the observation of seeding phenomena in vitro, why is it that, unlike prions, TTR aggregates are apparently K-resistant PrP Sc in a cultured cell system . Regardless of whether conformation or noninfectious? Is this a property of the greater stability of PrP Sc ? Or are the respective aggregates processed covalent differences are responsible, it seems possible that strain-specific properties of incubation time and differently by the various organ systems involved? Concerning such potentially different physiology, two obserbrain localization may reflect targeting of different forms of PrP Sc to specific CNS cells. These cells would then vations seem worth noting. In the case of TTR, a mechanism that clears TTR fibrils has recently been shown impart the same form to the newly-converted molecules (Hecker et al., 1992; Weissmann et al., 1997) . (Tan et al., 1995) ; and, in the case of prion disease, it has been observed that, even following intracerebral While primary structural differences are not necessary to produce different strains, an example of primary seinoculation of mice with prions, there is early acquisition of infectivity in the spleen, long preceding any appearquence origin of strain properties in human prion disease has recently been reported (Telling et al., 1996b) . ance of infectivity in the brain (Eklund et al., 1967; Kimberlin and Walker, 1979; Weissmann et al., 1997) .
Human D178N FFI is associated with a proteinase K-resistant PrP Sc of 19 kDa after deglycosylation, while Consistent with a primary replication step in the lymphoreticular system that favors neuroinvasion, SCID mice both familial and sporadic CJD are associated with a 21 kDa species. Inoculation of the respective human were relatively resistant to CNS disease following intraperitoneal inoculation (only 6 affected out of 18 animals), brain homogenates into Prp-deleted mice containing a chimeric mouse-human mouse (MHuM) PrP transgene compared with immunocompetent littermates (13 of 14 animals) (Lasmé zas et al., 1996a; see also Kitamoto et produced disease associated with the respectively sized PrP Sc , indicating that the two distinct PrP Sc species al., 1991). Presumably, those SCID animals that developed disease acquired CNS infection by direct neural can template a single primary MHuM PrP structure into different conformations. spread, suggested in early studies to extend from pe-
The importance of studying the origin and nature of ripheral nervous system to spinal cord to brain (e.g., strain differences has been emphasized recently by the Kimberlin and Walker, 1979) .
reports of a number of cases of vCJD that appear to be linked to BSE epidemic in British cattle .
Prion "Strains": Multiple Distinct PrP Sc Conformations
Despite the small number of cases, a number of observaPerhaps one of the most difficult phenomena to fathom tions suggests that vCJD represents a novel disease in light of a protein only hypothesis is the existence distinct from sporadic CJD. First, vCJD has a distinct of distinct prion "strains," reflecting observations that pathology characterized by abundant "florid plaques," infectious material from different sources can produce decorated by a daisy-like pattern of vacuolation ( Figure  1) . Second, there is a far younger age of onset than in distinct and reproducible patterns of incubation time, sporadic CJD. The notion that vCJD could be transmitand Rose, 1992; Smart et al., 1995) . Supporting a role of such a compartment, treatment of the cultured cell ted from cattle to primates was supported by the observation that intracerebral inoculation of BSE-infected system with the inhibitor of cholesterol biosynthesis, lovastatin, blocked the conversion process, but it was brain extract into Macaque monkeys produced disease and pathology resembling that in the vCJD patients (Lasunclear whether this effect was mediated by failure of PrP C to reach the cell surface or by disruption of the mé zas et al., 1996b). This raised the possibility that vCJD was a newly-identified strain of prion that was less re-DIGS where conversion might take place . Additional uncertainty is cast by the obserstricted by the species barrier. This was supported recently by studies examining the pattern of proteinase vation that absence of the GPI anchor from a truncated PrP inhibited but did not prevent production of the pro-K-resistant PrP Sc species from the vCJD patients, in particular comparing di-, mono-, and non-glycosylated teinase K-resistant PrP Sc species in the cultured cells (Rogers et al., 1993) . species with those from brain homogenates of patients with sporadic or iatrogenic CJD, and homogenates from Whatever the specific compartments involved, it seems clear that PrP C reaches the cell surface and that BSE-infected animals including cats and macaque (Collinge et al., 1996) . vCJD was observed to share a this localization may make it an easily accessible target for exogenous PrP Sc , although it seems equally clear that common pattern with BSE-infected animals, distinct from that of sporadic or acquired CJD. The proteinase PrP Sc presented from outside the cell could internalize down the same pathway as PrP C and mediate conver-K-resistant diglycosylated species was particularly prominent, raising questions of whether this form of PrP C sion internally. Whichever the site, the notion that conversion could take place in a specific membranous comis more susceptible to BSE-mediated conformational change or whether a population of cells preferentially partment containing a specific subset of proteins has potential for reconstitution studies. If such a PrP C -conproducing diglycosylated PrP may be more readily targeted by BSE (Aguzzi and Weissmann, 1996) . taining compartment is isolable as a low density Tritoninsoluble membrane fraction, it should be possible to test for conversion with the isolated fraction, potentially Conversion Process In Vivo allowing the delimiting of components that are critical The failure thus far to demonstrate conversion of PrP C to conversion. to an infectious form in vitro underscores the need for Recent transgenic studies on the susceptibility of a better understanding of the factors present in vivo mice expressing chimeric human-mouse PrP C suggest that facilitate this process. Studies of the biosynthesis that at least one host factor other than PrP C , tentatively and processing of the PrP proteins in cultured cells termed factor X, might be involved in susceptibility to have provided important clues to where the conversion infection (Telling et al., 1995) . Conceivably, factor X process might take place (Butler et al., 1988; could be a molecular chaperone that binds to PrP C and et al., 1989) . These studies indicate that the protein assists in altering its conformation. A precedent for normally traverses the secretory pathway to reach the chaperone involvement in a conversion process comes cell surface where it faces the external environment, from recent studies in yeast, where the cytosolically anchored to the plasma membrane via a GPI anchor localized product of the SUP35 gene, involved with attached at its COOH terminus (Stahl et al, 1987) . In translational termination, can be converted to a biologireaching this destination, an NH2-terminal secretory sigcally inactive aggregated molecule, conferring a phenonal peptide of 22 amino acids is cleaved, and 23 COOHtype of nonsense suppression (PSIϩ) (Chernoff et al., terminal residues are also processed during addition of 1995; Patino et al., 1996; Paushkin et al., 1996 ; see also the anchor to S231. In scrapie-infected cultured cells, Masison and Wickner, 1995) . The SUP35 aggregates PrP C was observed to undergo turnover with a t1/2 ϭ ‫6ف‬ appear to act as a nucleus, promoting the aggregation hr (Caughey et al., 1989) , but slow conversion of a small of newly synthesized SUP35 protein, allowing propagafraction ‫)%5ف(‬ of newly synthesized, metabolicallytion of the PSIϩ state in a manner analogous to the PrP Clabeled PrP C was observed (t 1/2 ϭ ‫51-5ف‬ hr), to a form to-PrP Sc conversion process. Strikingly, maintenance of that exhibited the same proteinase K resistance as PrP Sc the PSIϩ state was found to depend on the molecular and that accumulated (Borchelt et al., 1990; Caughey chaperone, Hsp104, a large homohexameric single ring and Raymond, 1991) . structure with two ATP-binding sites in each of its subAdditional studies in the cultured cell system showed units, which has previously been shown to have a prothat conversion to PrP Sc could be blocked by addition pensity to dissociate protein aggregates produced by of exogenous PI-specific phospholipase C or by proteheat shock (Parsell et al., 1994) . Remarkably, either deleases, suggesting that PrP C undergoes conversion either tion of Hsp104 or its overexpression resulted in concorat the cell surface or after internalization from the cell dant disappearance of the SUP35 aggregates and loss surface into the endocytic pathway (Caughey and Ray- of the PSIϩ state. In the case of PrP conversion, a mond, 1991; Borchelt et al., 1992) . In support of a regeneral chaperone component like Hsp104 has not so quirement for internalization, low temperature incubafar been identified in the cellular locations where convertion (18ЊC), which retards endocytosis, also blocked sion appears to occur. production of PrP Sc (Borchelt et al., 1992) . Additional efforts to refine the localization have noted that GPI-anchored proteins localize at the cell surface in Structural Studies of PrP C Ultimately, an understanding of the conversion process cholesterol-rich plasma membrane invaginations that are Triton X-100 insoluble, known as DIGS (detergentwill likely require knowledge of the three-dimensional structure of the different PrP conformations. A major insoluble glycosphingolipid-enriched membranes) (Brown The sequence of the mature protein, residues 23-231, after proteolytic processing of the NH2-terminal secretory signal and the COOH-terminal region beyond the GPI anchor site, is shown. Mutations involved with inherited human disease are indicated in red, above the line, and naturally occurring polymorphisms are shown as numerator/denominator on the line, in purple. The asterisk indicates a mutation producing a stop codon at amino acid 145. Residues implicated in species barriers are also shown, between human and mouse (backlit in blue), and between mouse and hamster (backlit in yellow). Secondary structure of corresponding region 123-231 of mouse PrP, determined from the NMR structure (Riek et al., 1996) , is shown above the primary sequence, with ␤ strands represented by arrows and ␣ helices by cylinders. (B) Structure of mouse prion protein domain PrP121-231. Two opposite faces are shown of the mouse PrP121-231 structure recently determined by NMR (taken from Riek et al., 1996, with permission) . Ribbon diagrams are shown in the two left panels, displaying the three ␣ helices and the short antiparallel two-stranded ␤ sheet. In the top left panel, green indicates well resolved loop structure, whereas purple indicates poorly resolved loop structure. A disulfide bond is shown in white. In the bottom left panel, side chains associated with inherited prion disease are shown in red, and residues that may be involved in the species barrier between mouse and human are shown in blue (Q168 side chain is not shown). (Note that side chain numbering corresponds to the human sequence shown in [A]). Two solvent-accessible glycosylation sites are also shown in green and the disulfide bond in yellow. Electrostatic potential plots are shown in the two right panels, displaying positive charge as blue and negative charge as red. The aspect of the molecule shown in the top panel has been suggested to possibly face a membrane, whereas the opposite, negatively-charged aspect (lower panels) may present a binding surface for an as yet unidentified ligand (see text).
advance in this direction is the recent NMR structure conformational transition to the ␤ sheet-rich PrP Sc form, that could presumably incorporate neighboring loops. determination of a mouse PrP molecule containing residues 121-231 (Riek et al., 1996 and see Figure 3 ). This Interestingly, the methionine/valine polymorphism affecting disposition to CJD maps into one of these polypeptide was stable and soluble when programmed in E.coli for localization to the periplasm, and it comstrands. The observation that heterozygosity for Met/ Val at this position is protective (Palmer et al., 1991) prises a significant portion of a minimal region of PrP, residues 80-231, that can mediate disease (Fischer et leaves one to wonder whether these strands might also be involved in intermolecular contacts involved in either al., 1996; see also Muramoto et al., 1996) . Given its solubility at millimolar concentration, and a high ␣ helix/ the conversion process or in aggregation of PrP Sc . Analysis of the surface properties of the PrP121-231 low ␤ sheet composition, it seems probable that it occupies a conformation similar to that in intact PrP C . molecule reveal two disparate faces ( Figure 3B ). One is overall electrostatically positive but contains interminThe secondary structure of PrP121-231 features three ␣ helices and two short antiparallel ␤ strands ( Figure  gled hydrophobic patches, suggesting that it could face the cell membrane. The opposite face, by contrast, is 3B). Glockshuber, Wuthrich, and coworkers speculate that this latter feature could be a "nucleation site" for a electrostatically negative, containing the two sites of (Brandner et al., 1996a) . They enthis surface bears at one edge containing the first ␣ helix, a region suggested to act as an accessible binding grafted brain tissue from a PrP C -expressing normal mouse into a null animal and then inoculated with mouse site for PrP Sc . This region contains 5 of 14 residues implicated by chimeric transgenic studies to be important prions. They observed the characteristic pathology of prion disease precisely within the engrafted tissue, but for either the human-mouse or hamster-mouse species barrier ( Figure 3A and 3B) . Three of the remaining resinot within the null tissue. Nevertheless, PrP Sc produced within the diseased tissue migrated into the neighboring dues involved in the species barrier lie at the opposite edge of the molecule, located in a loop region between null tissue. Thus, PrP Sc by itself was insufficient to produce disease-i.e., simple exposure to exogenous PrP Sc the second ␤ strand and the second ␣ helix (only 166 is shown in Figure 3B ). The remaining five residues form is insufficient for cytotoxicity. Rather, PrP Sc may be toxic only when formed within the cell, or when presented a third putative PrP Sc binding site located between residues 90 and 122, a region not present in the structure.
from outside to a cell already expressing PrP C , so that conversion ensues either at the cell surface or in an Interestingly, the sites of the species barrier and of disposing human mutations appear to be, so far, mutuinternalized compartment. Furthermore, Brandner and colleagues have also shown that propagation of infecally exclusive. Whereas the region including ␣ helix 1 appears to be a determinant of the species barrier, hution across neural pathways in the CNS requires the presence of PrP C along the pathway (Brandner et al., man mutations disposing to disease map to the region of the two other ␣ helices, with three mapping into the 1996b), insofar as grafts in null animals did not become infected following intraocular inoculation. Thus, in all hydrophobic core and three to the electrostatically negative surface. Such mutations could, correspondingly,
cases, it appears that the presence of PrP C is required for pathogenesis. either destabilize the structure or affect ligand binding.
With structural information of this sort now in hand, it will be possible to carry out a host of structure-function Perspective studies relating the regions of the species barrier and An enormous body of data reveals the central role of human mutations to the conversion process. For examthe PrP protein in a group of related transmissible neurople, it should be possible to assess the relative impordegenerative diseases. These data demonstrate that tance of the three structural regions implicated in the PrP protein is required for the disease process and that species barrier. In addition, designed mutants with eithe conformational conversion of the PrP protein from ther decreased or increased PrP C stability, measured its normal soluble ␣-helical conformation to an insoluble in vitro with purified recombinant protein, will make it ␤ sheet state is intimately tied to the generation of dispossible to test directly whether destabilization of the ease and infectivity. Much about the conversion process native PrP C structure facilitates conversion in vivo. Firemains unclear. In particular, is introduction of the PrP Sc nally, antibodies generated against peptides that are protein alone sufficient for infection in the presence of buried in the native PrP C structure may potentially proPrP C ? What is the nature of the conformational change? vide reagents for specifically detecting the PrP Sc form. Given the ubiquitous distribution of PrP C , why is prion While PrP C is at last yielding to structural analysis, by pathology restricted to the central nervous system? contrast, in the absence of protocols for solubilizing What determines the species barrier? In addition to furPrP Sc , structural information on the converted form may ther resolving a fascinating biological process, the exporequire nonsolution techniques such as solid state NMR sure of both cows and people to BSE underscores a (e.g., Heller et al., 1996) . need to answer these questions. Lledo et al., 1996) , an effect that could be rescued by a transgene (Whittington et al., 1995) , Aguzzi, A., and Weissmann, C. (1996) . A suspicious signature. Nature pointing to a possible postsynaptic function of PrP 
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